References
- Grills IS, Yan DY, Martinez AA, Vicini FA, Wong JW, Kestine LL. Potential for reduced toxicity and dose escalation in the treatment of imoperable non-small cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT) 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-890 https://doi.org/10.1016/S0360-3016(03)00743-0
- Onn A, Vaporciyan AA, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the lung. In: Kufe DW, Bast RC, Hait WN, et al. Cancer Medicine. 7th ed. Hamilton, London: BC Decker Inc. 2006:1179-1224
- Huang EH, Liao Z, Cox JD, et al. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys 2007;68:779-785 https://doi.org/10.1016/j.ijrobp.2007.01.002
- Choi Y, Lee HS, Hur WJ, et al. Impact of intensity modulated radiation therapy as a boost treatment on the lung dose distributions for non-small-cell lung cancer. Lung Cancer 2005;4:6-14
- Rojas AM, Lyn BE, Wilson EM, et al. Toxicity and outcome of a phase II trial of Taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. Cancer 2006;107:1321-1330 https://doi.org/10.1002/cncr.22123
- Giraud P, De Rycke Y, Lavole A, Milleron B, Cosset J-M, Rosenzweig KE. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Int J Radiat Oncol Biol Phys 2006;64:127-135 https://doi.org/10.1016/j.ijrobp.2005.06.043
- Dong L, Mohan R. Intensity-modulated radiation therapy, physics and quality assurance. In: Chao KSC, Apisarnthanarax S, Ozigit G. Practical Essentials of Intensity Modulated Radiation Therapy. 2nd ed. Philadelphia, Baltimore, NY, London, Hongkong, Sydney, Tokyo: Lippincott Williams & Wilkins. 2005:2-19
- Boyer AL. Intensity modulated radiation therapy. In: Khan FM. Treatment Planning in Radiation Oncology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2007:142-165
- Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and tree-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399-1407 https://doi.org/10.1016/j.ijrobp.2006.07.1337
- Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483-491 https://doi.org/10.1016/j.ijrobp.2006.05.008
- Seibert RM, Ramsey CR, Hines JW, et al. A model for predicting lung cancer response to therapy. Int J Radiat Oncol Biol Phys 2007;67:601-609 https://doi.org/10.1016/j.ijrobp.2006.09.051
- Wu KL, Jiang GL, Liao Y, et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 2003;57:2336-1344
- Hope AJ, Linsay PE, Naqa IE, et al. Modeling radiation pneumonitis risk with clinical, dosimetric and spatial parameters. Int J Radiat Oncol Biol Phys 2006;65:112-124 https://doi.org/10.1016/j.ijrobp.2005.11.046
- Wagner H Jr. Non-small-cell lung cancer. In: Gunderson LL, Tepper JE. Clinical Radiation Oncology. 2nd ed. Churchhill: Livingstone. 2007:911
- Travis EL, Komaki R. Treatment-related lung cancer. In: Pass HI, Carbone DP, Minna JD, Johnson DH, Turrisi AT III. Lung Cancer. Principles and Practice. 3rd ed. Philadelphia, Baltimore, NY, London, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins. 2005:545-567
- Beckmann GK, Kolbl O, Krieger T, Wulf J, Flentje MP. How can we further improve radiotherapy for stage-III non-small-cell lung cancer? Lung cancer 2004;45S:125-132
- Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:741-747 https://doi.org/10.1016/j.ijrobp.2004.04.013
- Belderbos JSA, Heemsbergen WD, Jaeger KD, Baas P, Lebesque JV. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:126-134 https://doi.org/10.1016/j.ijrobp.2006.04.034
- Liu HH, Wang CW, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58:1268-1279 https://doi.org/10.1016/j.ijrobp.2003.09.085
- Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherpay for advanced-stage non-small-cell lung cancer. Int J Radiat Onol Biol Phys 2004;58:1258-1267 https://doi.org/10.1016/j.ijrobp.2003.09.086
- Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;66:1595-1596
- Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006;66:1281-1293 https://doi.org/10.1016/j.ijrobp.2006.08.058
- Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 2007;67:410-416 https://doi.org/10.1016/j.ijrobp.2006.09.030
- Bradley JD, Hope A, Naqa IE, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007;69:985-992 https://doi.org/10.1016/j.ijrobp.2007.04.077
- Weiss E, Ramakrishnan V, Keall PJ. Is there a selection bias in radiotherapy dose-escalation protocols? Int J Radiat Oncol Biol Phys 2007;68:1359-1365 https://doi.org/10.1016/j.ijrobp.2007.02.006
- Baisden JM, Romney DA, Reish AG, et al. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. Int J Radiat Oncol Biol Phys 2007;68:1229-1237 https://doi.org/10.1016/j.ijrobp.2007.03.024
- Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phy 2007;69:350-357 https://doi.org/10.1016/j.ijrobp.2007.03.011
- Miles EF, Kelsey CR, Kirkpatrick JP, Marks LB. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: Calculations from clinical trials. Int J Radiat Oncol Biol Phys 2007;68:1047-1052 https://doi.org/10.1016/j.ijrobp.2007.02.028
- Wall RJ, Schnapp LM. Radiation pneumonitis. Respiratory Care 2006;51:1255-1260
- Sekine I, Sumi M, Ito Y, et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother Oncol 2006;80:93-97 https://doi.org/10.1016/j.radonc.2006.06.007
- Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005;63:5-24 https://doi.org/10.1016/j.ijrobp.2005.03.047